ClinicalTrials.Veeva

Menu

Long-term (3 Months) Safety of Femtosecond-laser Assisted Cataract Surgery

T

Technolas Perfect Vision

Status and phase

Completed
Phase 4

Conditions

Cataract

Treatments

Device: Manual cataract surgery
Device: Femtosecond laser cataract surgery

Study type

Interventional

Funder types

Industry

Identifiers

NCT02023437
1304_3M

Details and patient eligibility

About

This clinical study is a prospective, post-market-clinical-follow-up study to investigate the long-term (3 months) safety of femtosecond laser assisted cataract surgery as a study follow-up extension to the Study #1304 titled as "A Multi-centre, Multi-surgeon, Randomized, Controlled, Prospective, Post-Market-Clinical-Follow-Up Study to Investigate the Impact of Cataract Grade on the Efficacy and Safety of Femtosecond-laser Assisted Lens Fragmentation Procedure".

Enrollment

132 patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Only the patients who were successfully enrolled in Study #1304 are eligible for this follow-up extension study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

132 participants in 2 patient groups

Experimental: Femtosecond laser cataract surgery
Experimental group
Description:
"Laser group": a pre-fragmentation of the ocular lens will be performed by VICTUS femtosecond laser lens fragmentation procedure.
Treatment:
Device: Femtosecond laser cataract surgery
Manual cataract surgery
Active Comparator group
Description:
"Manual": manual group acts as a control group where the lens fragmentation are performed manually without femtosecond laser assisted lens fragmentation
Treatment:
Device: Manual cataract surgery

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems